Human tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1

Molecular Cancer

Volumn 12, Issue 1, 2013, Pages

  Cao, Xuelei ^a   Zhang, Li ^b   Shi, Yongyu ^a   Sun, Yue ^a   Dai, Shen ^a   Guo, Chun ^a   Zhu, Faliang ^a   wang, Qun ^a   Wang, Jianing ^a   Wang, Xiaoyan ^a   Chen, Youhai H ^c   Zhang, Lining ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

HCC; Invasion; Metastasis; Rac1; TIPE2

Indexed keywords

F ACTIN; GELATINASE B; RAC1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 8 LIKE 2; UNCLASSIFIED DRUG; UROKINASE;

ACTIN POLYMERIZATION; ADULT; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER TISSUE; CELL MIGRATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; TUMOR INVASION;

MUS;

ACTINS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; HEP G2 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROTEIN MULTIMERIZATION; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TUMOR BURDEN; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84888148914     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-12-149     Document Type: Article

References (26)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in, 2008: GLOBOCAN 2008. Int J Cancer 2008, 2010(127):2893-2917.
2. Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000, 232:10-24. 10.1097/00000658-200007000-00003, 1421103, 10862190.
3. Sun H, Gong S, Carmody RJ, Hilliard A, Li L, Sun J, Kong L, Xu L, Hilliard B, Hu S, Shen H, Yang X, Chen YH. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 2008, 133:415-426. 10.1016/j.cell.2008.03.026, 2398615, 18455983.
4. Zhang Y, Wei X, Liu L, Liu S, Wang Z, Zhang B, Fan B, Yang F, Huang S, Jiang F, Chen YH, Yi F. TIPE2, a novel regulator of immunity, protects against experimental stroke. J Biol Chem 2012, 287:32546-32555. 10.1074/jbc.M112.348755, 3463367, 22859306.
5. Li D, Song L, Fan Y, Li X, Li Y, Chen J, Zhu F, Guo C, Shi Y, Zhang L. Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Immunol 2009, 133:422-427. 10.1016/j.clim.2009.08.014, 19748832.
6. Xi W, Hu Y, Liu Y, Zhang J, Wang L, Lou Y, Qu Z, Cui J, Zhang G, Liang X, Ma C, Gao C, Chen Y, Liu S. Roles of TIPE2 in hepatitis B virus-induced hepatic inflammation in humans and mice. Mol Immunol 2011, 48:1203-1208. 10.1016/j.molimm.2011.03.002, 21466895.
7. Zhang X, Wang J, Fan C, Li H, Sun H, Gong S, Chen YH, Shi Y. Crystal structure of TIPE2 provides insights into immune homeostasis. Nat Struct Mol Biol 2009, 16:89-90. 10.1038/nsmb.1522, 19079267.
8. Wang Z, Fayngerts S, Wang P, Sun H, Johnson DS, Ruan Q, Guo W, Chen YH. TIPE2 protein serves as a negative regulator of phagocytosis and oxidative burst during infection. Proc Natl Acad Sci USA 2012, 109:15413-15418. 10.1073/pnas.1204525109, 3458374, 22949657.
9. Sun H, Zhuang G, Chai L, Wang Z, Johnson D, Ma Y, Chen YH. TIPE2 controls innate immunity to RNA by targeting the phosphatidylinositol 3-kinase-Rac pathway. J Immunol 2012, 189:2768-2773. 10.4049/jimmunol.1103477, 3436961, 22904303.
10. Gus-Brautbar Y, Johnson D, Zhang L, Sun H, Wang P, Zhang S, Chen YH. The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras. Mol Cell 2012, 45:610-618. 10.1016/j.molcel.2012.01.006, 3299909, 22326055.
11. Zhang G, Hao C, Lou Y, Xi W, Wang X, Wang Y, Qu Z, Guo C, Chen Y, Zhang Y, Liu S. Tissue-specific expression of TIPE2 provides insights into its function. Mol Immunol 2010, 47:2435-2442. 10.1016/j.molimm.2010.06.016, 20663561.
12. Zhang L, Shi Y, Wang Y, Zhu F, Wang Q, Ma C, Chen YH. The unique expression profile of human TIPE2 suggests new functions beyond its role in immune regulation. Mol Immunol 2011, 48:1209-1215. 10.1016/j.molimm.2011.03.001, 21459448.
13. Lee TK, Man K, Ho JW, Wang XH, Poon RT, Sun CK, Ng KT, Ng IO, Xu R, Fan ST. Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target. Carcinogenesis 2005, 26:681-687.
14. Jia YL, Shi L, Zhou JN, Fu CJ, Chen L, Yuan HF, Wang YF, Yan XL, Xu YC, Zeng Q, Yue W, Pei XT. Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis. Hepatology 2011, 54:1808-1818. 10.1002/hep.24562, 22045676.
15. Chen RX, Xia YH, Xue TC, Zhang H, Ye SL. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA. Oncol Rep 2011, 25:803-808.
16. Kumar D, Gokhale P, Broustas C, Chakravarty D, Ahmad I, Kasid U. Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells. Oncogene 2004, 23:612-616. 10.1038/sj.onc.1207123, 14724590.
17. Dong QZ, Zhao Y, Liu Y, Wang Y, Zhang PX, Jiang GY, Dong XJ, Cui QZ, Wang EH. Overexpression of SCC-S2 correlates with lymph node metastasis and poor prognosis in patients with non-small-cell lung cancer. Cancer Sci 2010, 101:1562-1569. 10.1111/j.1349-7006.2010.01557.x, 20398053.
18. Cui J, Zhang G, Hao C, Wang Y, Lou Y, Zhang W, Wang J, Liu S. The expression of TIPE1 in murine tissues and human cell lines. Mol Immunol 2011, 48:1548-1555. 10.1016/j.molimm.2011.04.023, 21600655.
19. Liu S, Yu M, He Y, Xiao L, Wang F, Song C, Sun S, Ling C, Xu Z. Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology 2008, 47:1964-1973. 10.1002/hep.22240, 18506888.
20. Santibanez JF, Kocic J, Fabra A, Cano A, Quintanilla M. Rac1 modulates TGF-beta1-mediated epithelial cell plasticity and MMP9 production in transformed keratinocytes. FEBS Lett 2010, 584:2305-2310. 10.1016/j.febslet.2010.03.042, 20353788.
21. Han Q, Leng J, Bian D, Mahanivong C, Carpenter KA, Pan ZK, Han J, Huang S. Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells. J Biol Chem 2002, 277:48379-48385. 10.1074/jbc.M209542200, 12377770.
22. Dise RS, Frey MR, Whitehead RH, Polk DB. Epidermal growth factor stimulates Rac activation through Src and phosphatidylinositol 3-kinase to promote colonic epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 2008, 294:G276-285.
23. Cadamuro M, Nardo G, Indraccolo S, Dall'olmo L, Sambado L, Moserle L, Franceschet I, Colledan M, Massani M, Stecca T, Bassi N, Morton S, Spirli C, Fiorotto R, Fabris L, Strazzabosco M. Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma. Hepatology 2013, 58:1042-1053.
24. Tan TL, Fang N, Neo TL, Singh P, Zhang J, Zhou R, Koh CG, Chan V, Lim SG, Chen WN. Rac1 GTPase is activated by hepatitis B virus replication-involvement of HBX. Biochim Biophys Acta 2008, 1783:360-374. 10.1016/j.bbamcr.2007.10.024, 18086571.
25. Wu L, Cai C, Wang X, Liu M, Li X, Tang H. MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells. FEBS Lett 2011, 585:1322-1330. 10.1016/j.febslet.2011.03.067, 21482222.
26. Roney KE, O'Connor BP, Wen H, Holl EK, Guthrie EH, Davis BK, Jones SW, Jha S, Sharek L, Garcia-Mata R, Bear JE, Ting JP. Plexin-B2 negatively regulates macrophage motility, Rac, and Cdc42 activation. PLoS One 2011, 6:e24795. 10.1371/journal.pone.0024795, 3179467, 21966369.